Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2012
05/09/2012CN101503458B Small molecule polypeptide for preventing and treating angiogenesis and use thereof
05/09/2012CN101475643B Double single chain antibody strengthened fusion protein dFv-LDP-AE, preparation and use thereof
05/09/2012CN101260151B Sea purse blood vessel generation inhibitive factor 1, and application thereof in preparing medicament
05/09/2012CN101195656B Recombined Japanese lamprey glandulae oris excreted L-250 protein anticoagulant efficacy
05/09/2012CN101146532B Pharmaceutical compounds
05/09/2012CN101098674B Use of a complex nutritional base in cosmetics, in particular for the hair
05/09/2012CN101068830B Protein allergens derivative
05/09/2012CN101056890B Deamidated interferon-beta
05/08/2012USRE43371 Use of selected cyclosporins for the treatment of hepatitis C infection
05/08/2012US8173796 Oligonucleotide compositions and methods for treating disease including inflammatory conditions
05/08/2012US8173793 Nucleic acids encoding modulators of body weight
05/08/2012US8173790 Insect desiccation resistance genes and uses thereof
05/08/2012US8173782 Fusion protein comprising growth hormone and growth hormone receptor
05/08/2012US8173776 Recombinant gelatins
05/08/2012US8173775 Collagen-like protein CLAC, a precursor thereof, and genes encoding the same
05/08/2012US8173774 Polypeptides and use thereof
05/08/2012US8173770 Intermediates for LHRH antagonist synthesis, process for the production, and process for LHRH antagonist production
05/08/2012US8173768 Peptides having antimicrobial and neurotrophic activity and uses thereof
05/08/2012US8173707 Ophthalmologic irrigation solutions and method
05/08/2012US8173615 TRPM-2 antisense therapy
05/08/2012US8173604 Inhibition of Skp2-cyclin a interaction
05/08/2012US8173603 Methods of using BTL-II proteins
05/08/2012US8173602 Detecting CYP24 expression level as a marker for predisposition to cancer
05/08/2012US8173601 Activin-ActRIIa antagonists and uses for treating multiple myeloma
05/08/2012US8173600 Caspase-2 inhibitors and their biological applications
05/08/2012US8173599 Spray-dried collectin compositions and process for preparing the same
05/08/2012US8173598 Myeloid protein activation of anti-inflammatory and anti-hypoxic pathway
05/08/2012US8173597 Modified recombinant factor VIII and von Willebrand factor and methods of use
05/08/2012US8173596 Administering prouroguanylin and a diuretic; kidney disease, heart disease, liver disease, hypertension
05/08/2012US8173595 Methods and compositions for the inhibition of thrombus formation
05/08/2012US8173594 Stabilizing alkylglycoside compositions and methods thereof
05/08/2012US8173593 Methods and compositions for emergency contraception using endothelin receptor antagonists
05/08/2012US8173592 Method for a programmed controlled ovarian stimulation protocol
05/08/2012US8173591 Variants of pigment epithelium derived factor and uses thereof
05/08/2012US8173424 Internalizing ErbB2 antibodies
05/08/2012US8173392 In vivo incorporation of unnatural amino acids
05/08/2012US8173364 Methods and composition for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs
05/08/2012US8173363 Random transposon insertion in Staphylococcus aureus and use thereof to identify essential genes
05/08/2012US8173168 Dispersible macromolecule compositions and methods for their preparation and use
05/08/2012US8173148 Stabilized polymeric delivery system comprising a water-insoluble polymer and an organic liquid
05/08/2012US8173138 Stable liquid formulations of botulinum toxin
05/08/2012US8173133 Acyl pseudodipeptides which carry a functionalized auxiliary arm
05/08/2012US8173131 Compositions and methods for modulating RSV infection and immunity
05/08/2012US8173129 Methods and compositions for treating autoimmune diseases
05/08/2012US8173128 Methods and compositions for inducing apoptosis in cancer cells with an anti-DR5 antibody
05/08/2012US8173125 Wise/Sost nucleic acid sequences and amino acid sequences
05/08/2012US8173122 Methods of treatment using antibodies to neutrokine-alpha
05/08/2012US8173121 Lysyl oxidase-like 1 (LOXL1) and elastogenesis
05/08/2012US8173120 Method of preventing reduced feed intake in animals and treatment of disease conditions
05/08/2012US8173118 Using stem cell culture to propagate heart grafts; regenerative medicine; tissue repair; tissue engineering
05/08/2012US8173117 Mouse CX3C chemokine polypeptides
05/08/2012CA2736104C A method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
05/08/2012CA2631841C Fast-acting oral peptide pharmaceutical products
05/08/2012CA2623339C Virulence genes in the vgc2 cluster of salmonella
05/08/2012CA2589095C Protein formulation for administering an active enamel substance
05/08/2012CA2533338C Viral vectors
05/08/2012CA2532565C Use of calcitonin in osteoarthritis
05/08/2012CA2529604C Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
05/08/2012CA2520541C Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field
05/08/2012CA2514356C Novel inhibitors of formation of advanced glycation endproducts (ages)
05/08/2012CA2475097C Anti-inflammatory peptides
05/08/2012CA2473135C Stabilised mrna tumour vaccine
05/08/2012CA2458386C L-methionine as a stabilizer for nesp/epo in hsa-free formulations
05/08/2012CA2421447C Collections of repeat proteins comprising repeat modules
05/08/2012CA2388041C High mannose proteins and methods of making high mannose proteins
05/08/2012CA2383724C Drug delivery system using membrane mimetics
05/08/2012CA2362264C Cytokine-binding domain
05/08/2012CA2353574C Analogues of glp-1
05/08/2012CA2340593C Use of vegf-c or vegf-d gene or protein to prevent restenosis
05/08/2012CA2284271C A preventive or therapeutic agent for sensitized t cell-mediated diseases comprising il-6 antagonist as an active ingredient
05/08/2012CA2266859C Colostrinin, and uses thereof
05/08/2012CA2229741C Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
05/08/2012CA2163211C Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
05/03/2012WO2012058616A2 Engineered kinetochores and uses thereof
05/03/2012WO2012058585A2 Methods of treatment with natriuretic peptides
05/03/2012WO2012058480A1 Fviii peptides for immune tolerance induction and immunodiagnostics
05/03/2012WO2012058479A2 Method of improving transplant function using soluble complement receptor type i (scr1)
05/03/2012WO2012058292A2 Parathyroid hormone variants and assays related to disease
05/03/2012WO2012058291A2 Methods and compositions for differentiating embryonic stem cells
05/03/2012WO2012058220A2 Anti-sod1 antibodies and uses thereof
05/03/2012WO2012057713A1 Antimicrobial peptides
05/03/2012WO2012057636A1 Modulation of th1 and th2 immune response by lactic acid whey
05/03/2012WO2012057624A1 Novel bicyclic peptide mimetics
05/03/2012WO2012057525A2 Liquid formulations of long acting interferon alpha conjugate
05/03/2012WO2012057421A1 Cancer-metastasis suppression by means of increased task-3 potassium channel expression
05/03/2012WO2012057343A1 Nad(p)h oxidase inhibitor, therapeutic agent for oxidative stress-related diseases, therapeutic method for oxidative stress-related diseases, and screening method
05/03/2012WO2012057294A1 Method for treating malaria, method for killing malaria parasite, and use of the methods
05/03/2012WO2012056215A1 Non-natural gelatin-like proteins with enhanced functionality
05/03/2012WO2012056120A1 Use of a modulator of the patched protein for regulating intracellular cholesterol concentration
05/03/2012WO2012056044A1 Treatment for dupuytren's disease
05/03/2012WO2012056024A1 Composition comprising a combination of at least one proteolytic enzyme and at least one lipolytic enzyme, for use in preventing triglyceride synthesis
05/03/2012WO2012055967A2 Treating diabetes melitus using insulin injections administered with varying injection intervals
05/03/2012WO2012055933A1 Liposome-based construct comprising a peptide modified through hydrophobic moieties
05/03/2012WO2012055878A2 Method of treatment
05/03/2012WO2012055826A1 TREATMENT OF MeCP2-ASSOCIATED DISORDERS
05/03/2012WO2012055162A1 Momordica charantia polypeptide, preparation method therefor and use thereof
05/03/2012WO2012055083A1 Fusion protein comprising vegi, pharmaceutical composition and use thereof
05/03/2012WO2012054998A1 Method for labelling with radionuclides somatostatin analogues associated with diseases with physiopathogenesis involving somatostatin receptors, reagent for in vivo and/or in vitro diagnosis on the basis of somatostatin analogues linked to radionuclides, method for diagnosing in vitro or in vivo diseases with physiopathogenesis involving somatostatin receptors, using the thus obtained reagent, and kit containing said reagent for diagnosing diseases with physiopathogenesis involving somatostatin
05/03/2012WO2012031342A3 Polymer system and method for encapsulating human amylin and agonist analogues, and use thereof; released amylin functional evaluation method
05/03/2012WO2012018856A3 Hiv vaccine therapy with concomitant antiviral monotherapy
1 ... 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 ... 3163